Corporate Overview Statutory Reports Financial Statements 161 Note 29.4 Related party disclosures (continued) (` cr) Note 29.4 (J) outstanding balances as at year end As at March 31, 2024 As at March 31, 2023 e) With entities over which key management personnel or their close family members have significant influence 1. Receivables 0.10 0.05 Atul Foundation Health Center 0.00 - Atul Foundation Trust 0.03 0.02 Atul Kelavani Mandal 0.01 0.01 Atul Rural Development Fund 0.01 0.00 Atul Vidyalaya Trust 0.05 0.02 Urmi Stree Sanstha 0.00 0.00 2. Payables 0.09 0.05 Atul Foundation Trust 0.00 0.00 Atul Rural Development Fund 0.00 - Atul Vidyalaya Trust 0.09 0.05 Note 29.4 (K) Terms and conditions 1. Sales to and purchases from related parties were made on normal commercial terms and conditions and at prevailing market prices or where market price is not available at cost plus margin. 2. Transactions relating to dividends were on the same terms and conditions that applied to other shareholders. Subscriptions of additional equity shares were on a preferential basis. 3. All outstanding balances are repayable in cash and cash equivalent. Note 29.5 Current and deferred tax The major components of income tax expense for the years ended March 31, 2024, and March 31, 2023, are: a) Income tax expense recognised in the Statement of Profit and Loss: (` cr) Particulars 2023-24 2022-23 i) Current tax Current tax on profit for the year 105.49 170.06 Adjustments for current tax of prior periods - 0.23 Total current tax expense 105.49 170.29 ii) Deferred tax (Decrease) | Increase in deferred tax liabilities 20.68 3.96 Decrease | (Increase) in deferred tax assets (1.23) 3.81 Total deferred tax expense | (benefit) 19.45 7.77 Income tax expense 124.94 178.06
RkJQdWJsaXNoZXIy MjA2MDI2